基于解剖学CT衍生肺通气成像的功能性避肺质子放疗计划
本研究在18例肺癌患者中利用计划CT生成的解剖学肺通气成像(VIaw)制定功能性避肺质子治疗计划,评估其对高功能肺体积(HFV)和可恢复低功能肺体积(rLFV)的保护作用。结果显示功能性IMPT较fIMRT显著降低所有HFV剂量参数,在8例气管阻塞患者中rfIMPT较fIMPT显著降低rLFV剂量,且IMPT对危及器官保护持续优于IMRT。
要点
- 功能性IMPT较fIMRT显著降低HFV所有剂量参数(均p<0.05)。
- 气管阻塞患者中rfIMPT较fIMPT显著降低rLFV的V20、V30和平均剂量。
- IMPT对侧肺平均剂量约为IMRT的四分之一。
核心结论
- 将VIaw纳入功能性质子计划可有效增强对HFV和rLFV的剂量保护,同时维持良好的危及器官保护。
研究设计与样本
- 研究纳入18例肺癌患者,由计划CT生成VIaw,为每例制定aIMRT、fIMRT、aIMPT和fIMPT计划。
- 对8例肿瘤致气管阻塞患者额外制定rfIMRT和rfIMPT计划,专门加入同时保护HFV和rLFV的约束。
主要发现
- 18例患者中fIMPT较fIMRT显著降低HFV所有剂量参数:V5为34.9%±18.1%、V20为20.6%±17.0%、V30为9.6%±17.4%、平均剂量为25.3%±10.5%,均p<0.05。
- fIMPT较aIMPT也显示额外显著的保护作用。
- 8例气管阻塞患者中rfIMPT较fIMPT显著降低rLFV剂量:V20为11.4%±6.2%、V30为16.4%±5.9%、平均剂量为13.0%±4.7%,均p<0.05。
- rfIMPT较rfIMRT在V5降低方面具优势(4.5%±5.4%,p<0.05)。
- IMPT计划在危及器官保护方面持续优于IMRT,对侧肺平均剂量降至IMRT约四分之一。
临床怎么用
- 可利用计划CT生成的VIaw识别HFV和rLFV,在质子计划优化中同时施加保护约束。
- 对肿瘤致气管阻塞患者,可考虑在质子计划中额外加入rLFV保护约束以促进受损区域恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to assess the dosimetric benefits of functional avoidance proton therapy planning using anatomy-wise computed tomography (CT)-derived lung ventilation imaging (VIaw), which helps spare both high-functioning lung volume (HFV) and recoverable low-functioning lung volume (rLFV) for the first time in proton therapy. METHODS: In a cohort of 18 lung cancer patients, VIaw was generated from planning CT scans. For each patient, we created anatomical and functional-guided intensity-modulated radiation therapy (aIMRT, fIMRT) and proton therapy (aIMPT, fIMPT) plans. For a subset of eight patients with tracheal obstruction by the tumor, we generated two extra rLFV-sparing plans (rfIMRT, rfIMPT) that specifically incorporated constraints to spare both HFV and rLFV. RESULTS: For the 18 patients, functional IMPT (fIMPT) demonstrated superior HFV sparing, achieving statistically significant reductions in all HFV dose parameters compared to fIMRT (V5: 34.9%±18.1%; V20: 20.6%±17.0%; V30: 9.6%±17.4%; mean dose: 25.3%±10.5%; all p < 0.05) and additional significant sparing compared to aIMPT. For the eight patients with tracheal obstruction by the tumor, rfIMPT significantly reduced rLFV dose compared to fIMPT (V20: 11.4%±6.2%; V30: 16.4%±5.9%; mean dose: 13.0%±4.7%; all p < 0.05) and showed advantages over rfIMRT, particularly in V5 reduction (4.5%±5.4%, p < 0.05). IMPT plans consistently outperformed IMRT in OAR sparing, reducing contralateral lung mean dose to approximately one-fourth of IMRT levels. Other dosimetric parameters for rfIMPT and fIMPT were comparable and within acceptable limits. CONCLUSIONS: Incorporating VIaw into functional proton planning effectively enhanced dose sparing of HFV and rLFV while maintaining excellent OAR protection. This approach demonstrates the potential of proton therapy to simultaneously preserve functional lung regions and facilitate recovery of compromised areas. CLINICAL TRIAL NUMBER: Not applicable.
引用
- Chen Z, Xiong T, Huang YH, et al. Functional lung avoidance proton radiation therapy planning using anatomy-wise computed tomography-derived lung ventilation imaging. Radiat Oncol. 2026. PMID: 41832521. doi:10.1186/s13014-026-02804-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。